Literature DB >> 18097192

Transcortical approach to a huge pineal mature teratoma.

Moncef Berhouma1, Hafedh Jemel, Iadh Ksira, Moncef Khaldi.   

Abstract

Intracranial teratomas are rare germ cell neoplasms occurring more often during childhood. We report the case of a huge mature teratoma of the pineal region in a 10-year-old patient that was not correctly diagnosed preoperatively by stereotactic biopsy. The tumor was revealed by intracranial hypertension and a Parinaud syndrome. The tumor markers were within normal levels in the serum. A left transcortical parietal approach was used to completely resect the tumor. No adjuvant treatment was given. A complete neurological recovery was observed after the surgical procedure. Follow-up at 2 years did not show any recurrence. Pineal mature teratomas have a good prognosis, in contrast to their immature or mixed counterparts. A rigorous histological examination of the tumor samples is mandatory, in order to not omit a mixed contingent within the tumor. The treatment is exclusively surgical. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18097192     DOI: 10.1159/000110663

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Arterial vascularization of the pineal gland.

Authors:  Gokmen Kahilogullari; Hasan Caglar Ugur; Ayhan Comert; Recep Ali Brohi; Onur Ozgural; Mevci Ozdemir; Suleyman Tuna Karahan
Journal:  Childs Nerv Syst       Date:  2013-01-20       Impact factor: 1.475

2.  Management of mature pineal region teratomas in pediatric age group.

Authors:  Bahattin Tanrıkulu; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2019-05-29       Impact factor: 1.475

Review 3.  Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview.

Authors:  Giuseppe Lombardi; Pietro Luigi Poliani; Renzo Manara; Moncef Berhouma; Giuseppe Minniti; Emeline Tabouret; Evangelia Razis; Giulia Cerretti; Vittorina Zagonel; Michael Weller; Ahmed Idbaih
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.